アデノシン三リン酸（ATP）アッセイの世界市場レポート 2025年

アデノシン三リン酸（ATP）アッセイの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は12.0％で、34億6,000万米ドルに成長します。予測期間の成長は、バイオ医薬品産業の継続的成長、個別化医療アプローチの拡大、飲食品の安全性重視の高まり、アッセイプラットフォームの技術革新、産業プロセスでの応用拡大などに起因すると考えられます。予測期間における主な動向には、ATP検出技術の進歩、ハイスループットスクリーニング需要の高まり、臨床診断への統合、飲食品安全性試験の重視、スポーツやパフォーマンスモニタリングへの応用などがあります。

がん、慢性疾患、感染症の罹患率の上昇は、アデノシン三リン酸（ATP）アッセイ市場の今後の成長を促進すると予測されています。がんは、制御不能な細胞増殖を特徴とし、近隣の組織に浸潤して損傷を与え、身体の他の部位に転移する可能性があります。慢性疾患は、一般的にゆっくりと発症し、長期間にわたって持続する安定した状態の疾患です。感染症は、細菌、ウイルス、真菌、寄生虫など、人から人へ感染する病原性微生物によって引き起こされます。ATPアッセイは、細胞生存能の評価、微生物汚染の検出、治療効果の評価、代謝およびミトコンドリア機能障害のモニタリングにより、これらの疾患の重要な診断ツールとして機能します。例えば、2024年2月、スイスに本部を置く国連機関である世界保健機関（WHO）は、2050年までに新たに発生するがん患者は3,500万人を超え、2022年の推定2,000万人から77％増加すると予測しました。さらに2021年、ベルギーに本部を置く糖尿病コミュニティに焦点を当てた組織である国際糖尿病連合は、約5億3,700万人の成人が糖尿病を患っていると報告し、その数は2045年までに7億8,300万人に増加すると予想しました。したがって、がん、慢性疾患、感染症の有病率の増加がATP測定器市場を牽引しています。

個別化治療アプローチに対する需要の高まりが、アデノシン三リン酸（ATP）アッセイ市場の拡大に拍車をかけると予想されます。個別化治療とは、病気の予防、発見、治療を効果的に行うために、個人に固有の遺伝子やタンパク質の構成に関する知識を活用することです。感染症治療では、特定の病原体に対する抗菌薬の有効性を評価し、個別化治療戦略の選択に役立てるATP測定が重要な役割を果たしています。例えば、米国食品医薬品局（FDA）は2022年に12の個別化医薬品を承認しており、これは個別化医療連合（Personalized Medicine Coalition）の報告によると、新たに承認された全治療用分子実体の約34％を占めます。このような個別化医療に対する需要の急増は、アデノシン三リン酸（ATP）アッセイ市場の成長を促進する上で極めて重要な役割を担っていることを裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のアデノシン三リン酸（ATP）アッセイ市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアデノシン三リン酸（ATP）アッセイ市場：成長率分析
• 世界のアデノシン三リン酸（ATP）アッセイ市場の実績：規模と成長、2019～2024年
• 世界のアデノシン三リン酸（ATP）アッセイ市場の予測：規模と成長、2024～2029年、2034年
• 世界のアデノシン三リン酸（ATP）アッセイ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアデノシン三リン酸（ATP）アッセイ市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 発光ATP（アデノシン三リン酸）アッセイ
• 酵素ATP（アデノシン三リン酸）アッセイ
• 生物発光共鳴エネルギー移動（BRET）ATP（アデノシン三リン酸）アッセイ
• 細胞ベースのATP（アデノシン三リン酸）アッセイ
• その他
• 世界のアデノシン三リン酸（ATP）アッセイ市場：コンポーネント別、実績と予測、2019～2024年、2024～2029年、2034年
• 消耗品および付属品
• 機器
• 世界のアデノシン三リン酸（ATP）アッセイ市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 創薬・開発
• 臨床診断
• 環境試験
• 食品安全性と品質のテスト
• その他
• 世界のアデノシン三リン酸（ATP）アッセイ市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 製薬およびバイオテクノロジー企業
• 食品・飲料業界
• 病院および診断研究所
• 学術研究機関
• 世界のアデノシン三リン酸（ATP）アッセイ市場：発光ATPアッセイのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ルシフェラーゼベースのアッセイ
• 化学発光アッセイ
• 世界のアデノシン三リン酸（ATP）アッセイ市場：酵素ATPアッセイのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• キナーゼベースのアッセイ
• ATPase活性アッセイ
• 世界のアデノシン三リン酸（ATP）アッセイ市場：生物発光共鳴エネルギー移動（BRET）ATPアッセイのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• タンパク質間相互作用のためのBRET
• 創薬のためのBRET
• 世界のアデノシン三リン酸（ATP）アッセイ市場：細胞ベースのATPアッセイのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生細胞ATP測定
• 細胞生存率アッセイ
• 世界のアデノシン三リン酸（ATP）アッセイ市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 蛍光ATPアッセイ
• 分光光度法によるATPアッセイ

第7章 地域別・国別分析

• 世界のアデノシン三リン酸（ATP）アッセイ市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のアデノシン三リン酸（ATP）アッセイ市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アデノシン三リン酸（ATP）アッセイ市場：競合情勢
• アデノシン三リン酸（ATP）アッセイ市場：企業プロファイル
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agilent Technologies Inc.
• Abcam plc
• Danaher Corporation
• 3M Co.
• Geno Technology Inc.
• NEOGEN Corporation
• Biomerieux SA
• AAT Bioquest Inc.
• MBL International Corporation
• Charm Sciences Inc.
• Cell Signaling Technology Inc.
• Cayman Chemical Company
• Vazyme Biotech Co. Ltd.
• SignalChem Lifesciences Corporation
• Kaneka Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アデノシン三リン酸（ATP）アッセイ市場2029年：新たな機会を提供する国
• アデノシン三リン酸（ATP）アッセイ市場2029年：新たな機会を提供するセグメント
• アデノシン三リン酸（ATP）アッセイ市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

ATP assays, or adenosine triphosphate assays, serve as analytical procedures to determine ATP concentrations in biological materials. ATP, an energy-carrying molecule present in cells of all living organisms, extracts chemical energy from the breakdown of food molecules and utilizes it to power various cellular functions. This assay plays a crucial role in monitoring cellular energy state and function, serving as a vital tool in research, diagnostics, and drug discovery.

The primary types of ATP assays include luminometric ATP assays, enzymatic ATP assays, bioluminescence resonance energy transfer (BRET) ATP assays, cell-based ATP assays, among others. Luminometric ATP assays, specifically, leverage bioluminescence principles to measure ATP levels in samples. They are widely used in research, drug discovery, and biomedical applications for assessing cellular energy status, measuring enzymatic activity, evaluating cell viability, and screening ATP-modulating compounds. These assays consist of essential components such as consumables, accessories, and instruments utilized across diverse fields including drug discovery and development, clinical diagnostics, environmental testing, and food safety and quality assessment. Their applications extend to various end-users such as pharmaceutical and biotechnology companies, the food and beverage industry, hospitals, diagnostics laboratories, as well as academic and research institutions.

The adenosine triphosphate (ATP) assays market research report is one of a series of new reports from The Business Research Company that provides adenosine triphosphate (ATP) assays market statistics, including adenosine triphosphate (ATP) assays industry global market size, regional shares, competitors with an adenosine triphosphate (ATP) assays market share, detailed adenosine triphosphate (ATP) assays market segments, market trends and opportunities, and any further data you may need to thrive in the adenosine triphosphate (ATP) assays industry. This adenosine triphosphate (ATP) assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adenosine triphosphate (ATP) assays market size has grown rapidly in recent years. It will grow from$1.99 billion in 2024 to $2.2 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to biomedical research advancements, drug discovery and development, rise in adoption in clinical diagnostics, environmental monitoring requirements, increased focus on cell-based assays

The adenosine triphosphate (ATP) assays market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to continued growth in biopharmaceutical industry, expansion of personalized medicine approaches, increased emphasis on food and beverage safety, technological innovations in assay platforms, growing application in industrial processes. Major trends in the forecast period include advancements in ATP detection technologies, rising demand for high-throughput screening, integration in clinical diagnostics, emphasis on food and beverage safety testing, application in sports and performance monitoring.

The rising incidence of cancer, chronic diseases, and infectious diseases is projected to drive the growth of the adenosine triphosphate (ATP) assay market in the future. Cancer is marked by uncontrolled cell growth that can invade and damage nearby tissues and may spread to other parts of the body. Chronic diseases are stable conditions that generally develop slowly and persist over a long period. Infectious diseases are caused by pathogenic microorganisms that can be transmitted from one person to another, including bacteria, viruses, fungi, or parasites. ATP assays serve as an important diagnostic tool for these diseases by evaluating cellular viability, detecting microbial contamination, assessing treatment effectiveness, and monitoring metabolic and mitochondrial dysfunction. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will occur by 2050, representing a 77% increase from an estimated 20 million cases in 2022. Additionally, in 2021, the International Diabetes Federation, a Belgium-based organization focused on the diabetic community, reported that approximately 537 million adults have diabetes, with that number expected to rise to 783 million by 2045. Therefore, the growing prevalence of cancer, chronic, and infectious diseases is driving the ATP assay market.

The growing demand for personalized treatment approaches is expected to fuel the expansion of the adenosine triphosphate (ATP) assays market. Personalized treatments involve utilizing knowledge about an individual's unique genetic or protein makeup to prevent, detect, or treat diseases effectively. In the context of infectious disease management, ATP assays play a crucial role by assessing the efficacy of antimicrobial agents against specific pathogens, aiding in the selection of personalized treatment strategies. For instance, the US Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition. This surge in demand for personalized medicine underscores its pivotal role in driving the growth of the adenosine triphosphate (ATP) assays market.

The rising prevalence of chronic diseases is projected to drive the growth of the adenosine triphosphate (ATP) assays market in the coming years. Chronic diseases are illnesses that persist for three months or longer and can worsen over time. Several factors contribute to the increasing prevalence of these conditions, including an aging population, unhealthy lifestyle choices, and rapid urbanization, which lead to a rise in diseases such as diabetes, cardiovascular disease, and respiratory illnesses. ATP, the main energy carrier in cells, is measured through ATP assays to investigate disruptions in cellular energy metabolism, which are often linked to chronic diseases like diabetes, cancer, and neurodegenerative disorders. This understanding helps researchers better comprehend disease progression and develop new therapeutic strategies. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will be diagnosed by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the ATP assays market.

The evolution of novel assays stands out as a prominent trend gaining momentum within the adenosine triphosphate (ATP) assay market. Key companies operating in this domain are introducing groundbreaking products, such as the SensiLux kit by BC Aplicaciones, a biotechnology firm based in Spain. The SensiLux kit is a unique testing solution designed for detecting microbial ATP in samples, utilizing bioluminescence for detection following sample pre-incubation. Its applications extend to areas such as food safety and contamination testing. Additionally, this offering includes ATP kits featuring advanced multi-injector automatic luminometers, proprietary control software, and future-oriented robot-based sample automation, providing customers with tailored solutions. BC Aplicaciones' programming and computer systems department have developed unique software to manage robot and luminometer operations.

Leading companies in the adenosine triphosphate (ATP) assays market are concentrating on creating advanced kinase testing platforms to offer highly sensitive assays. A kinase testing platform is a specialized system designed to assess kinase activity in biological samples, supporting drug discovery and development by providing insights into kinase function and inhibition. For example, in April 2024, Reaction Biology, a biotechnology firm based in the U.S., launched the HotSpot(TM) ATP-Max KinomeScreen, an advanced assay for high-throughput kinase screening that features enhanced sensitivity, allowing testing at ATP levels as low as 1 mM. This innovative platform utilizes a gold standard filter binding radiometric assay to assess kinase activity across the broadest range of kinase targets in the industry. By providing physiologically relevant data, the HotSpot ATP-Max KinomeScreen enables researchers to identify more potent and specific kinase inhibitors, thereby advancing drug discovery efforts and aiding the development of targeted therapies for various diseases, particularly cancer.

Major companies operating in the adenosine triphosphate (ATP) assays market include Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, 3M Co., Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adenosine triphosphate (atp) assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adenosine triphosphate (ATP) assays market consists of revenues earned by entities by providing testing services related to colorimetric and fluorescent assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The adenosine triphosphate (ATP) assays market also includes sales of luminometer, and chemiluminescent which are used in adenosine triphosphate (ATP) assay services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adenosine Triphosphate (ATP) Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adenosine triphosphate (atp) assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adenosine triphosphate (atp) assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adenosine triphosphate (atp) assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays; Enzymatic ATP (Adenosine Triphosphate) Assays; Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays; Cell-Based ATP (Adenosine Triphosphate) Assays; Other Types
• 2) By Component: Consumables And Accessories; Instruments
• 3) By Application: Drug Discovery And Development; Clinical Diagnostics; Environmental Testing; Food Safety And Quality Testing; Other Applications
• 4) By End User: Pharmaceutical And Biotechnology Companies; Food and Beverage Industry; Hospitals And Diagnostics Laboratories; Academic And Research Institutions
• Subsegments:
• 1) By Luminometric ATP Assays: Luciferase-Based Assays; Chemiluminescent Assays
• 2) By Enzymatic ATP Assays: Kinase-Based Assays; ATPase Activity Assays
• 3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions; BRET For Drug Discovery
• 4) By Cell-Based ATP Assays: Live-Cell ATP Measurement; Cell Viability Assays
• 5) By Other Types: Fluorescent ATP Assays; Spectrophotometric ATP Assays
• Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Lonza Group; Promega Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Adenosine Triphosphate (ATP) Assays Market Characteristics

3. Adenosine Triphosphate (ATP) Assays Market Trends And Strategies

4. Adenosine Triphosphate (ATP) Assays Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Adenosine Triphosphate (ATP) Assays Growth Analysis And Strategic Analysis Framework

• 5.1. Global Adenosine Triphosphate (ATP) Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Adenosine Triphosphate (ATP) Assays Market Growth Rate Analysis
• 5.4. Global Adenosine Triphosphate (ATP) Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Adenosine Triphosphate (ATP) Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Adenosine Triphosphate (ATP) Assays Total Addressable Market (TAM)

6. Adenosine Triphosphate (ATP) Assays Market Segmentation

• 6.1. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Luminometric ATP (Adenosine Triphosphate) Assays
• Enzymatic ATP (Adenosine Triphosphate) Assays
• Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays
• Cell-Based ATP (Adenosine Triphosphate) Assays
• Other Types
• 6.2. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables And Accessories
• Instruments
• 6.3. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Development
• Clinical Diagnostics
• Environmental Testing
• Food Safety And Quality Testing
• Other Applications
• 6.4. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Food and Beverage Industry
• Hospitals And Diagnostics Laboratories
• Academic And Research Institutions
• 6.5. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Luminometric ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Luciferase-Based Assays
• Chemiluminescent Assays
• 6.6. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Enzymatic ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kinase-Based Assays
• ATPase Activity Assays
• 6.7. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• BRET For Protein-Protein Interactions
• BRET For Drug Discovery
• 6.8. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Cell-Based ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live-Cell ATP Measurement
• Cell Viability Assays
• 6.9. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent ATP Assays
• Spectrophotometric ATP Assays

7. Adenosine Triphosphate (ATP) Assays Market Regional And Country Analysis

• 7.1. Global Adenosine Triphosphate (ATP) Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Adenosine Triphosphate (ATP) Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market

• 8.1. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adenosine Triphosphate (ATP) Assays Market

• 9.1. China Adenosine Triphosphate (ATP) Assays Market Overview
• 9.2. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adenosine Triphosphate (ATP) Assays Market

• 10.1. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adenosine Triphosphate (ATP) Assays Market

• 11.1. Japan Adenosine Triphosphate (ATP) Assays Market Overview
• 11.2. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adenosine Triphosphate (ATP) Assays Market

• 12.1. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adenosine Triphosphate (ATP) Assays Market

• 13.1. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adenosine Triphosphate (ATP) Assays Market

• 14.1. South Korea Adenosine Triphosphate (ATP) Assays Market Overview
• 14.2. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adenosine Triphosphate (ATP) Assays Market

• 15.1. Western Europe Adenosine Triphosphate (ATP) Assays Market Overview
• 15.2. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adenosine Triphosphate (ATP) Assays Market

• 16.1. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adenosine Triphosphate (ATP) Assays Market

• 17.1. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adenosine Triphosphate (ATP) Assays Market

• 18.1. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adenosine Triphosphate (ATP) Assays Market

• 19.1. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adenosine Triphosphate (ATP) Assays Market

• 20.1. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adenosine Triphosphate (ATP) Assays Market

• 21.1. Eastern Europe Adenosine Triphosphate (ATP) Assays Market Overview
• 21.2. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adenosine Triphosphate (ATP) Assays Market

• 22.1. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adenosine Triphosphate (ATP) Assays Market

• 23.1. North America Adenosine Triphosphate (ATP) Assays Market Overview
• 23.2. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adenosine Triphosphate (ATP) Assays Market

• 24.1. USA Adenosine Triphosphate (ATP) Assays Market Overview
• 24.2. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adenosine Triphosphate (ATP) Assays Market

• 25.1. Canada Adenosine Triphosphate (ATP) Assays Market Overview
• 25.2. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adenosine Triphosphate (ATP) Assays Market

• 26.1. South America Adenosine Triphosphate (ATP) Assays Market Overview
• 26.2. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adenosine Triphosphate (ATP) Assays Market

• 27.1. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adenosine Triphosphate (ATP) Assays Market

• 28.1. Middle East Adenosine Triphosphate (ATP) Assays Market Overview
• 28.2. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adenosine Triphosphate (ATP) Assays Market

• 29.1. Africa Adenosine Triphosphate (ATP) Assays Market Overview
• 29.2. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape And Company Profiles

• 30.1. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape
• 30.2. Adenosine Triphosphate (ATP) Assays Market Company Profiles
  • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Adenosine Triphosphate (ATP) Assays Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. Abcam plc
• 31.3. Danaher Corporation
• 31.4. 3M Co.
• 31.5. Geno Technology Inc.
• 31.6. NEOGEN Corporation
• 31.7. Biomerieux SA
• 31.8. AAT Bioquest Inc.
• 31.9. MBL International Corporation
• 31.10. Charm Sciences Inc.
• 31.11. Cell Signaling Technology Inc.
• 31.12. Cayman Chemical Company
• 31.13. Vazyme Biotech Co. Ltd.
• 31.14. SignalChem Lifesciences Corporation
• 31.15. Kaneka Corporation

32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adenosine Triphosphate (ATP) Assays Market

34. Recent Developments In The Adenosine Triphosphate (ATP) Assays Market

35. Adenosine Triphosphate (ATP) Assays Market High Potential Countries, Segments and Strategies

• 35.1 Adenosine Triphosphate (ATP) Assays Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Adenosine Triphosphate (ATP) Assays Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Adenosine Triphosphate (ATP) Assays Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer